Key facts
- This page summarizes Oleg Nodelman's Form 3 filing for Zymeworks Inc. (ZYME).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Feb 2025, 15:48.
Oleg Nodelman - 17 Feb 2025 Form 3 Insider Report for Zymeworks Inc. (ZYME)
- Reporting relationship
- Director, 10%+ Owner
- Issuer ticker
- ZYME
- Reported as of
- 17 Feb 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 18 Feb 2025, 15:48:01 UTC
- Prior SEC filing
- 22 Sep 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Oleg Nodelman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Oleg Nodelman filed Form 3 for Zymeworks Inc. (ZYME) on 18 Feb 2025.
Change
- Previous filing in this sequence was filed on 22 Sep 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ZYME
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,720,161
- Date
- 17 Feb 2025
- Ownership
- See Note
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ZYME
holding
Derivative
Pre-Funded Warrants
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Feb 2025
- Ownership
- See Note
- Underlying class
- Common Stock
- Underlying amount
- 5,086,521
- Exercise price
- $0.000100
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Mr. Nodelman is the manager and controlling owner of EcoR1 Capital, LLC which is the investment adviser and general partner of private funds. The funds hold these securities directy for the benefit of their investors. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1 Capital, LLC. Mr. Nodelman disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Footnote F2
The pre-funded warrants do not have an expiration date.
Footnote F3
Each pre-funded warrant is exercisable to purchase one share of Common Stock, except that the pre-funded warrants cannot be exercised if, after giving effect or immediately prior to such exercise, the reporting person, together with its affiliates and any other persons whose beneficial ownership of shares of Common Stock would be aggregated with the reporting person for purposes of Section 13(d) of the Securities Exchange Act of 1934, would beneficially own more than 19.99% of the total number of issued and outstanding shares of Common Stock or voting power of the Company following such exercise.
SEC remarks
Mr. Nodelman is filing this Form 3 to report that he was appointed to the issuer's board of directors on February 17, 2025. Mr. Nodelman previously reported his beneficial ownership of the securities included in this report in the Forms 3 and Forms 4 filed by EcoR1 Capital, LLC.